# The Tolerance, Pharmacokinetics of Jaktinib in Healthy Volunteers

> **NCT03314402** · PHASE1 · COMPLETED · sponsor: **Suzhou Zelgen Biopharmaceuticals Co.,Ltd** · enrollment: 126 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Jaktinib Dihydrochloride Monohydrate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT03314402
- **Lead sponsor:** Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-28
- **Primary completion:** 2018-08-30
- **Final completion:** 2018-09-27
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2019-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03314402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03314402, "The Tolerance, Pharmacokinetics of Jaktinib in Healthy Volunteers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03314402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*